QuickView: Established and growing digital health player
LifeWatch’s remote diagnostic monitoring services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. Digital health is a rapidly advancing sector that is playing an ever important role in the trend towards a more holistic approach to diagnosing, treating and monitoring diseases. LifeWatch specialises in ECG-based cardiac monitoring devices and systems. H115 revenues rose 9.1% to $52.5m, driven by growth in the US market, and the firm posted its best EBIT ($3.8m) and EBITDA ($7.2m) numbers since 2009.Lifewatch is a specialist in telemedicine monitoring services and a developer, manufacturer and marketer of wireless healthcare technologies and products. These services and devices are used to assess a broad array of physiological functions that allow patients to be monitored and treated in their normal, everyday environment. Co.'s primary service offering is cardiac monitoring, as well as monitors for the following services: ACT, Event, Holter and Pacemaker. Co. functions in two business segments: Monitoring services and the sale of systems.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.